More attention should be paid to the treatment of male infertility with drugs—testosterone: to use it or not?
Testosterone replacement is strictly contraindicated for the treatment of male infertility’ was the advanced view from the ‘2013 European Association of Urology (EAU) guidelines on male infertility’, and this view brings extensive concern and questions. Although sufficient numbers of well-performed...
Main Author: | |
---|---|
Format: | Online |
Language: | English |
Published: |
Medknow Publications & Media Pvt Ltd
2014
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3955339/ |
id |
pubmed-3955339 |
---|---|
recordtype |
oai_dc |
spelling |
pubmed-39553392014-03-25 More attention should be paid to the treatment of male infertility with drugs—testosterone: to use it or not? Li, Hong-Jun Opinion Testosterone replacement is strictly contraindicated for the treatment of male infertility’ was the advanced view from the ‘2013 European Association of Urology (EAU) guidelines on male infertility’, and this view brings extensive concern and questions. Although sufficient numbers of well-performed and controlled clinical trials that provide evidence supporting drug treatment of male infertility are not available at present, the opportunity to prove that these drugs are effective should not be prevented, and rigorous examination of drug therapy should be encouraged and strengthened. Therefore, I believe the above conclusion in the EAU guidelines is poorly conceived. Medknow Publications & Media Pvt Ltd 2014 2014-01-20 /pmc/articles/PMC3955339/ /pubmed/24435051 http://dx.doi.org/10.4103/1008-682X.122343 Text en Copyright: © Asian Journal of Andrology http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
repository_type |
Open Access Journal |
institution_category |
Foreign Institution |
institution |
US National Center for Biotechnology Information |
building |
NCBI PubMed |
collection |
Online Access |
language |
English |
format |
Online |
author |
Li, Hong-Jun |
spellingShingle |
Li, Hong-Jun More attention should be paid to the treatment of male infertility with drugs—testosterone: to use it or not? |
author_facet |
Li, Hong-Jun |
author_sort |
Li, Hong-Jun |
title |
More attention should be paid to the treatment of male infertility with drugs—testosterone: to use it or not? |
title_short |
More attention should be paid to the treatment of male infertility with drugs—testosterone: to use it or not? |
title_full |
More attention should be paid to the treatment of male infertility with drugs—testosterone: to use it or not? |
title_fullStr |
More attention should be paid to the treatment of male infertility with drugs—testosterone: to use it or not? |
title_full_unstemmed |
More attention should be paid to the treatment of male infertility with drugs—testosterone: to use it or not? |
title_sort |
more attention should be paid to the treatment of male infertility with drugs—testosterone: to use it or not? |
description |
Testosterone replacement is strictly contraindicated for the treatment of male infertility’ was the advanced view from the ‘2013 European Association of Urology (EAU) guidelines on male infertility’, and this view brings extensive concern and questions. Although sufficient numbers of well-performed and controlled clinical trials that provide evidence supporting drug treatment of male infertility are not available at present, the opportunity to prove that these drugs are effective should not be prevented, and rigorous examination of drug therapy should be encouraged and strengthened. Therefore, I believe the above conclusion in the EAU guidelines is poorly conceived. |
publisher |
Medknow Publications & Media Pvt Ltd |
publishDate |
2014 |
url |
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3955339/ |
_version_ |
1612068090673102848 |